The epidemiology of invasive fungal infections is changing, with new populations at risk and
the emergence of resistance caused by the selective pressure from increased usage of …

Vulvovaginal candidiasis (VVC) is a prevalent infection of the genitourinary tract affecting
millions of women worldwide. In the present study, the importance of virulence factors …

Vulvovaginal candidiasis (VVC) is a vaginal infection caused by abnormal growth of
Candida sp., especially Candida albicans, in the vaginal mucosa. A shift in vaginal …

Background Candida albicans (C. albicans) is a major cause of vulvovaginal candidiasis
(VVC), a condition that is commonly treated with azole agents. Biofilm formation and aspartyl …

Background Vaginal discharge syndrome (VDS) is a common condition. Clinical
management targets sexually transmitted infections (STIs) and bacterial vaginosis (BV); …

Candida glabrata is the most common non-albicans Candida species that causes
vulvovaginal candidiasis (VVC). Given the intrinsically low susceptibility of C. glabrata to …

Background and Objectives: Vulvovaginal candidiasis (VVC) is a mucous membrane
infection, with an increased rate of antifungal resistance of Candida species. In this study …

“Unity in strength” is a notion that can be exploited to characterize biofilms as they bestow
microbes with protection to live freely, escalate their virulence, confer high resistance to …

Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of
the most common gynecological infections, primarily caused by Candida species. Although …

Vulvovaginal candidosis (VVC) is one of the most frequent causes of gynecological
consultations. Therefore, the development of new antifungal therapies against VVC is …